# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-24-031948
Filing Date
2024-07-01
Accepted
2024-07-01 16:07:14
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | ny20031004x3_defa14a.htm | DEFA14A | 11432
2 |  | ny20031004x3_pc01.jpg | GRAPHIC | 495778
3 |  | ny20031004x3_pc02.jpg | GRAPHIC | 605804
| Complete submission text file | 0001140361-24-031948.txt |  | 1529141

Mailing Address 11611 N. MERIDIAN ST SUITE 330 CARMEL IN 46032
Business Address 11611 N. MERIDIAN ST SUITE 330 CARMEL IN 46032 (812) 689-0791
Neuraxis, INC (Filer) CIK: 0001933567 (see all company filings)

EIN.: 455079684 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-41775 | Film No.: 241090565
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 03 Life Sciences)